Gene · 4811
Papers2,052
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,052
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Lupus Nephritis Risk Factors and Biomarkers: An Update. | Int J Mol Sci | 2023 | 37833974 | PubTator, text mining | PubMed |
| Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives. | Cancer Med | 2023 | 37776168 | PubTator, text mining | PubMed |
| The contribution of reticular basement membrane proteins to basal airway epithelial attachment, spreading and barrier formation: implications for airway remodeling in asthma. | Front Med (Lausanne) | 2023 | 37771980 | PubTator, text mining | PubMed |
| The matrix microenvironment influences but does not dominate tissue-specific stem cell lineage differentiation. | Mater Today Bio | 2023 | 37766896 | PubTator, text mining | PubMed |
| Indicators of HSV1 Infection, ECM-Receptor Interaction, and Chromatin Modulation in a Nuclear Family with Schizophrenia. | J Pers Med | 2023 | 37763159 | PubTator, text mining | PubMed |
| Biomarkers for Kidney-Transplant Rejection: A Short Review Study. | Biomedicines | 2023 | 37760879 | PubTator, text mining | PubMed |
| Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? | Cell Commun Signal | 2023 | 37749597 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas. | Oncotarget | 2023 | 37737665 | PubTator, text mining | PubMed |
| In-silico identification and prioritization of therapeutic targets of asthma. | Sci Rep | 2023 | 37735578 | PubTator, text mining | PubMed |
| Neutrophil swarming: Is a good offense the best defense? | iScience | 2023 | 37670784 | PubTator, text mining | PubMed |
| The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability. | Cell Rep Med | 2023 | 37652015 | PubTator, text mining | PubMed |
| Serine protease 35 regulates the fibroblast matrisome in response to hyperosmotic stress. | Sci Adv | 2023 | 37647410 | PubTator, text mining | PubMed |
| All-Polymer Solar Cells Sequentially Solution Processed from Hydrocarbon Solvent with a Thick Active Layer. | Polymers (Basel) | 2023 | 37631520 | PubTator, text mining | PubMed |
| Neuroinflammatory Dysfunction of the Blood-Brain Barrier and Basement Membrane Dysplasia Play a Role in the Development of Drug-Resistant Epilepsy. | Int J Mol Sci | 2023 | 37628870 | PubTator, text mining | PubMed |
| An extensive β1-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathies. | JCI Insight | 2023 | 37606047 | PubTator, text mining | PubMed |
| Coalescent RNA-localizing and transcriptional activities of SAM68 modulate adhesion and subendothelial basement membrane assembly. | Elife | 2023 | 37585334 | PubTator, text mining | PubMed |
| Organoids: opportunities and challenges of cancer therapy. | Front Cell Dev Biol | 2023 | 37576596 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| TMT-based quantitative proteomic analysis revealed that FBLN2 and NPR3 are involved in the early osteogenic differentiation of mesenchymal stem cells (MSCs). | Aging (Albany NY) | 2023 | 37543430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4811/papers?page=7